{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:41:47Z","timestamp":1794296507161,"version":"4.9.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T00:00:00Z","timestamp":1703030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Joint Medical Research Project of Chongqing Science and Technology Commission & Chongqing Health and Family Planning Commission","award":["2022ZDXM003"],"award-info":[{"award-number":["2022ZDXM003"]}]},{"name":"The Chongqing Science and Health Joint Medical Research Project","award":["2020FYYX141"],"award-info":[{"award-number":["2020FYYX141"]}]},{"name":"The Innovative Funded Project of Chongqing Innovation and Retention Program","award":["cx2019032"],"award-info":[{"award-number":["cx2019032"]}]},{"name":"Youth Foundation of the National Natural Science Foundation","award":["82000744"],"award-info":[{"award-number":["82000744"]}]},{"name":"National Natural Science Foundation of China, Major Joint Project","award":["U21A20355"],"award-info":[{"award-number":["U21A20355"]}]},{"name":"National key research & development plan of China, major project of prevention and treatment for common diseases","award":["2022YFC2505301"],"award-info":[{"award-number":["2022YFC2505301"]}]},{"name":"National key research & development plan of China, major project of prevention and treatment for common diseases","award":["2022YFC2505302"],"award-info":[{"award-number":["2022YFC2505302"]}]},{"name":"National key research & development plan of China, major project of prevention and treatment for common diseases","award":["2022YFC2505306"],"award-info":[{"award-number":["2022YFC2505306"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82270878"],"award-info":[{"award-number":["82270878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870567"],"award-info":[{"award-number":["81870567"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970720"],"award-info":[{"award-number":["81970720"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170825"],"award-info":[{"award-number":["82170825"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and Technology Research Project of Chongqing Education Commission","award":["KJQN202200403"],"award-info":[{"award-number":["KJQN202200403"]}]},{"name":"Chongqing Outstanding Youth Funds","award":["cstc2019jcyjjq0006"],"award-info":[{"award-number":["cstc2019jcyjjq0006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background and Aims<\/jats:title>\n                <jats:p>Primary aldosteronism (PA) is an adrenal disorder of autonomous aldosterone secretion which promotes arterial injury. We aimed to explore whether PA is causally associated with lower-extremity arterial disease (LEAD).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included 39,713 patients with diabetes and 419,312 participants without diabetes from UK Biobank. We derived a polygenic risk score (PRS) for PA based on previous genome-wide association studies (GWAS). Outcomes included LEAD and LEAD related gangrene or amputation. We conducted a two-sample Mendelian randomization analysis for PA and outcomes to explore their potential causal relationship.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In whole population, individuals with a higher PA PRS had an increased risk of LEAD. Among patients with diabetes, compared to the subjects in the first tertile of PA PRS, subjects in the third tertile showed a 1.24-fold higher risk of LEAD (OR 1.24, 95% CI 1.03\u20131.49) and a 2.09-fold higher risk of gangrene (OR 2.09, 95% CI 1.27\u20133.44), and 1.72-fold higher risk of amputation (OR 1.72, 95% CI 1.10\u20132.67). Among subjects without diabetes, there was no significant association between PA PRS and LEAD, gangrene or amputation. Two-sample Mendelian randomization analysis indicated that genetically predictors of PA was significantly associated with higher risks of LEAD and gangrene (inverse variance weighted OR 1.20 [95% CI 1.08\u20131.34]) for LEAD, 1.48 [95% CI 1.28\u20131.70] for gangrene), with no evidence of significant heterogeneity or directional pleiotropy.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Primary aldosteronism is genetically and causally associated with higher risks of LEAD and gangrene, especially among patients with diabetes. Targeting on the autonomous aldosterone secretion may prevent LEAD progression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12933-023-02086-x","type":"journal-article","created":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T18:01:59Z","timestamp":1703095319000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Primary aldosteronism and lower-extremity arterial disease: a two-sample Mendelian randomization study"],"prefix":"10.1186","volume":"22","author":[{"given":"Jinbo","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenrui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhipeng","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingfeng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,20]]},"reference":[{"key":"2086_CR1","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1001\/jama.2021.2126","volume":"325","author":"TS Polonsky","year":"2021","unstructured":"Polonsky TS, McDermott MM. Lower extremity peripheral artery disease without chronic limb-threatening ischemia: a review. JAMA. 2021;325:2188\u201398.","journal-title":"JAMA"},{"key":"2086_CR2","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.mayocp.2020.07.036","volume":"96","author":"AS Tseng","year":"2021","unstructured":"Tseng AS, Girardo M, Firth C, et al. Lower extremity arterial disease as a predictor of incident atrial fibrillation and cardiovascular events. Mayo Clin Proc. 2021;96:1175\u201383.","journal-title":"Mayo Clin Proc"},{"key":"2086_CR3","doi-asserted-by":"publisher","first-page":"e171","DOI":"10.1161\/CIR.0000000000001005","volume":"144","author":"MH Criqui","year":"2021","unstructured":"Criqui MH, Matsushita K, Aboyans V, et al. Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American heart association. Circulation. 2021;144:e171\u201391.","journal-title":"Circulation"},{"key":"2086_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1177\/2047487319880044","volume":"26","author":"G Buso","year":"2019","unstructured":"Buso G, Aboyans V, Mazzolai L. Lower extremity artery disease in patients with type 2 diabetes. Eur J Prev Cardiol. 2019;26:114\u201324.","journal-title":"Eur J Prev Cardiol"},{"key":"2086_CR5","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41569-018-0005-0","volume":"15","author":"JS Hiramoto","year":"2018","unstructured":"Hiramoto JS, Teraa M, de Borst GJ, Conte MS. Interventions for lower extremity peripheral artery disease. Nat Rev Cardiol. 2018;15:332\u201350.","journal-title":"Nat Rev Cardiol"},{"key":"2086_CR6","doi-asserted-by":"publisher","DOI":"10.7326\/M20-0065","author":"JM Brown","year":"2020","unstructured":"Brown JM, Siddiqui M, Calhoun DA, et al. The unrecognized prevalence of primary aldosteronism. Ann Intern Med. 2020. https:\/\/doi.org\/10.7326\/M20-0065.","journal-title":"Ann Intern Med"},{"key":"2086_CR7","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1210\/er.2018-00139","volume":"39","author":"A Vaidya","year":"2018","unstructured":"Vaidya A, Mulatero P, Baudrand R, Adler GK. The expanding spectrum of primary aldosteronism: implications for diagnosis, pathogenesis, and treatment. Endocr Rev. 2018;39:1057\u201388.","journal-title":"Endocr Rev"},{"key":"2086_CR8","doi-asserted-by":"publisher","first-page":"630","DOI":"10.7326\/M17-0882","volume":"167","author":"JM Brown","year":"2017","unstructured":"Brown JM, Robinson-Cohen C, Luque-Fernandez MA, et al. The spectrum of subclinical primary aldosteronism and incident hypertension: a cohort study. Ann Intern Med. 2017;167:630\u201341.","journal-title":"Ann Intern Med"},{"key":"2086_CR9","doi-asserted-by":"publisher","first-page":"e023082","DOI":"10.1161\/JAHA.121.023082","volume":"10","author":"J Hu","year":"2021","unstructured":"Hu J, Shen H, Huo P, et al. Heightened cardiovascular risk in hypertension associated with renin-independent aldosteronism versus renin-dependent aldosteronism: a collaborative study. J Am Heart Assoc. 2021;10:e023082.","journal-title":"J Am Heart Assoc"},{"key":"2086_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ijcard.2016.01.200","volume":"208","author":"P Ambrosino","year":"2016","unstructured":"Ambrosino P, Lupoli R, Tortora A, et al. Cardiovascular risk markers in patients with primary aldosteronism: a systematic review and meta-analysis of literature studies. Int J Cardiol. 2016;208:46\u201355.","journal-title":"Int J Cardiol"},{"key":"2086_CR11","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1161\/01.ATV.14.12.1885","volume":"14","author":"ML Bots","year":"1994","unstructured":"Bots ML, Hofman A, Grobbee DE. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. the Rotterdam study. Arterioscler Thromb J Vasc Biol. 1994;14:1885\u201391.","journal-title":"Arterioscler Thromb J Vasc Biol"},{"key":"2086_CR12","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.atherosclerosis.2021.10.014","volume":"340","author":"K Stone","year":"2022","unstructured":"Stone K, Fryer S, Faulkner J, et al. Associations of lower-limb atherosclerosis and arteriosclerosis with cardiovascular risk factors and disease in older adults: the Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2022;340:53\u201360.","journal-title":"Atherosclerosis"},{"key":"2086_CR13","first-page":"1487","volume":"47","author":"YJ Li","year":"2009","unstructured":"Li YJ, Guan H, Ye W, Liu CW. Pulse wave velocity a sensitive predicator for peripheral artery disease among diabetic patients. Zhonghua wai ke za zhi [Chin J Surg]. 2009;47:1487\u201390.","journal-title":"Zhonghua wai ke za zhi [Chin J Surg]"},{"key":"2086_CR14","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.jvs.2008.06.039","volume":"48","author":"M Husmann","year":"2008","unstructured":"Husmann M, D\u00f6rffler-Melly J, Kalka C, Diehm N, Baumgartner I, Silvestro A. Successful lower extremity angioplasty improves brachial artery flow-mediated dilation in patients with peripheral arterial disease. J Vasc Surg. 2008;48:1211\u20136.","journal-title":"J Vasc Surg"},{"key":"2086_CR15","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1161\/01.CIR.0000095273.92468.D9","volume":"108","author":"G Brevetti","year":"2003","unstructured":"Brevetti G, Silvestro A, Schiano V, Chiariello M. Endothelial dysfunction and cardiovascular risk prediction in peripheral arterial disease: additive value of flow-mediated dilation to ankle-brachial pressure index. Circulation. 2003;108:2093\u20138.","journal-title":"Circulation"},{"key":"2086_CR16","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.atherosclerosis.2011.09.008","volume":"219","author":"A Hannemann","year":"2011","unstructured":"Hannemann A, Wallaschofski H, L\u00fcdemann J, et al. Plasma aldosterone levels and aldosterone-to-renin ratios are associated with endothelial dysfunction in young to middle-aged subjects. Atherosclerosis. 2011;219:875\u20139.","journal-title":"Atherosclerosis"},{"key":"2086_CR17","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, et al. Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement. JAMA. 2021;326:1614\u201321.","journal-title":"JAMA"},{"key":"2086_CR18","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S2215-0366(21)00286-8","volume":"8","author":"HJ Jones","year":"2021","unstructured":"Jones HJ, Borges MC, Carnegie R, et al. Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study. Lancet Psychiatry. 2021;8:1062\u201370.","journal-title":"Lancet Psychiatry"},{"key":"2086_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2022.08.012","author":"FR Wendt","year":"2022","unstructured":"Wendt FR, Garcia-Argibay M, Cabrera-Mendoza B, et al. The relationship of attention-deficit\/hyperactivity disorder with posttraumatic stress disorder: a two-sample Mendelian randomization and population-based sibling comparison study. Biol Psychiatry. 2022. https:\/\/doi.org\/10.1016\/j.biopsych.2022.08.012.","journal-title":"Biol Psychiatry"},{"key":"2086_CR20","doi-asserted-by":"publisher","first-page":"5198","DOI":"10.1038\/s41467-022-32896-8","volume":"13","author":"E Le Floch","year":"2022","unstructured":"Le Floch E, Cosentino T, Larsen CK, et al. Identification of risk loci for primary aldosteronism in genome-wide association studies. Nat Commun. 2022;13:5198.","journal-title":"Nat Commun"},{"key":"2086_CR21","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"2086_CR22","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/0895-4356(92)90150-L","volume":"45","author":"GC Leng","year":"1992","unstructured":"Leng GC, Fowkes FG. The Edinburgh claudication questionnaire: an improved version of the WHO\/Rose questionnaire for use in epidemiological surveys. J Clin Epidemiol. 1992;45:1101\u20139.","journal-title":"J Clin Epidemiol"},{"key":"2086_CR23","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1038\/s41588-019-0530-8","volume":"51","author":"L Jiang","year":"2019","unstructured":"Jiang L, Zheng Z, Qi T, et al. A resource-efficient tool for mixed model association analysis of large-scale data. Nat Genet. 2019;51:1749\u201355.","journal-title":"Nat Genet"},{"key":"2086_CR24","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1038\/s41588-021-00954-4","volume":"53","author":"L Jiang","year":"2021","unstructured":"Jiang L, Zheng Z, Fang H, Yang J. A generalized linear mixed model association tool for biobank-scale data. Nat Genet. 2021;53:1616\u201321.","journal-title":"Nat Genet"},{"key":"2086_CR25","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/ije\/dyw127","volume":"45","author":"DA Lawlor","year":"2016","unstructured":"Lawlor DA, Tilling K, Davey SG. Triangulation in aetiological epidemiology. Int J Epidemiol. 2016;45:1866\u201386.","journal-title":"Int J Epidemiol"},{"key":"2086_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","volume":"28","author":"S Burgess","year":"2017","unstructured":"Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from Mendelian randomization analyses with multiple genetic variants. Epidemiology. 2017;28:30\u201342.","journal-title":"Epidemiology"},{"key":"2086_CR27","doi-asserted-by":"publisher","first-page":"e1967","DOI":"10.1210\/clinem\/dgz306","volume":"105","author":"C van der Heijden","year":"2020","unstructured":"van der Heijden C, Smeets EMM, Aarntzen E, et al. Arterial wall inflammation and increased hematopoietic activity in patients with primary aldosteronism. J Clin Endocrinol Metab. 2020;105:e1967\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"2086_CR28","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","volume":"50","author":"AV Khera","year":"2018","unstructured":"Khera AV, Chaffin M, Aragam KG, et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat Genet. 2018;50:1219\u201324.","journal-title":"Nat Genet"},{"key":"2086_CR29","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1016\/j.jacc.2018.07.079","volume":"72","author":"M Inouye","year":"2018","unstructured":"Inouye M, Abraham G, Nelson CP, et al. Genomic risk prediction of coronary artery disease in 480,000 adults: implications for primary prevention. J Am Coll Cardiol. 2018;72:1883\u201393.","journal-title":"J Am Coll Cardiol"},{"key":"2086_CR30","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1038\/s41591-022-01767-6","volume":"28","author":"L Hao","year":"2022","unstructured":"Hao L, Kraft P, Berriz GF, et al. Development of a clinical polygenic risk score assay and reporting workflow. Nat Med. 2022;28:1006\u201313.","journal-title":"Nat Med"},{"key":"2086_CR31","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1161\/HYPERTENSIONAHA.116.07564","volume":"68","author":"A Manichaikul","year":"2016","unstructured":"Manichaikul A, Rich SS, Allison MA, et al. KCNK3 variants are associated with hyperaldosteronism and hypertension. Hypertension. 2016;68:356\u201364.","journal-title":"Hypertension"},{"key":"2086_CR32","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1161\/HYPERTENSIONAHA.113.02504","volume":"63","author":"A Spyroglou","year":"2014","unstructured":"Spyroglou A, Bozoglu T, Rawal R, et al. Diastrophic dysplasia sulfate transporter (SLC26A2) is expressed in the adrenal cortex and regulates aldosterone secretion. Hypertension. 2014;63:1102\u20139.","journal-title":"Hypertension"},{"key":"2086_CR33","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1536\/ihj.16-649","volume":"58","author":"T Hayashi","year":"2017","unstructured":"Hayashi T, Shibata H, Kurihara I, et al. High glucose stimulates mineralocorticoid receptor transcriptional activity through the protein kinase C \u03b2 signaling. Int Heart J. 2017;58:794\u2013802.","journal-title":"Int Heart J"},{"key":"2086_CR34","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1161\/HYPERTENSIONAHA.109.148783","volume":"55","author":"AW Krug","year":"2010","unstructured":"Krug AW, Allenh\u00f6fer L, Monticone R, et al. Elevated mineralocorticoid receptor activity in aged rat vascular smooth muscle cells promotes a proinflammatory phenotype via extracellular signal-regulated kinase 1\/2 mitogen-activated protein kinase and epidermal growth factor receptor-dependent pathways. Hypertension. 2010;55:1476\u201383.","journal-title":"Hypertension"},{"key":"2086_CR35","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1210\/jc.2016-3867","volume":"102","author":"GL Hundemer","year":"2017","unstructured":"Hundemer GL, Baudrand R, Brown JM, Curhan G, Williams GH, Vaidya A. Renin phenotypes characterize vascular disease, autonomous aldosteronism, and mineralocorticoid receptor activity. J Clin Endocrinol Metab. 2017;102:1835\u201343.","journal-title":"J Clin Endocrinol Metab"},{"key":"2086_CR36","doi-asserted-by":"publisher","first-page":"313","DOI":"10.2337\/db12-0905","volume":"62","author":"SB Bender","year":"2013","unstructured":"Bender SB, McGraw AP, Jaffe IZ, Sowers JR. Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease? Diabetes. 2013;62:313\u20139.","journal-title":"Diabetes"},{"key":"2086_CR37","doi-asserted-by":"publisher","first-page":"3515","DOI":"10.1093\/eurheartj\/eht095","volume":"34","author":"N Sch\u00e4fer","year":"2013","unstructured":"Sch\u00e4fer N, Lohmann C, Winnik S, et al. Endothelial mineralocorticoid receptor activation mediates endothelial dysfunction in diet-induced obesity. Eur Heart J. 2013;34:3515\u201324.","journal-title":"Eur Heart J"},{"key":"2086_CR38","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1161\/CIRCRESAHA.121.318258","volume":"128","author":"MP Bonaca","year":"2021","unstructured":"Bonaca MP, Hamburg NM, Creager MA. Contemporary medical management of peripheral artery disease. Circ Res. 2021;128:1868\u201384.","journal-title":"Circ Res"},{"key":"2086_CR39","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1097\/HJH.0000000000001989","volume":"37","author":"S Kishimoto","year":"2019","unstructured":"Kishimoto S, Oki K, Maruhashi T, et al. Eplerenone improves endothelial function and arterial stiffness and inhibits Rho-associated kinase activity in patients with idiopathic hyperaldosteronism: a pilot study. J Hypertens. 2019;37:1083\u201395.","journal-title":"J Hypertens"},{"key":"2086_CR40","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2011.12.003","volume":"221","author":"YH Lin","year":"2012","unstructured":"Lin YH, Lin LY, Chen A, et al. Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma. Atherosclerosis. 2012;221:154\u20139.","journal-title":"Atherosclerosis"},{"key":"2086_CR41","doi-asserted-by":"publisher","first-page":"e019434","DOI":"10.1161\/JAHA.120.019434","volume":"10","author":"SR Aryal","year":"2021","unstructured":"Aryal SR, Siddiqui M, Sharifov OF, et al. Spironolactone reduces aortic stiffness in patients with resistant hypertension independent of blood pressure change. J Am Heart Assoc. 2021;10:e019434.","journal-title":"J Am Heart Assoc"},{"key":"2086_CR42","first-page":"1181","volume":"18","author":"F Zeng","year":"2022","unstructured":"Zeng F, Huang R, Lu Y, Wu Z, Mai W, Wang L. Association of spironolactone treatment and arterial stiffness and cardiovascular disease in hypertensive patients. Arch Med Sci AMS. 2022;18:1181\u20137.","journal-title":"Arch Med Sci AMS"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-023-02086-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-023-02086-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,20]],"date-time":"2023-12-20T18:03:51Z","timestamp":1703095431000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-023-02086-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2086"],"URL":"https:\/\/doi.org\/10.1186\/s12933-023-02086-x","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,20]]},"assertion":[{"value":"4 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the National Health Service (NHS) National Research Ethics Service (11\/NW\/0382) and the UK Biobank Ethics and Governance Council. All participants provided written informed consent before taking part in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants in UK biobank provided informed consent through electronic signature at the first assessment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors have disclosed no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"352"}}